We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Urine Osmolality Measurement Evaluated on Automated Analyzer

By LabMedica International staff writers
Posted on 06 Oct 2020
Print article
Image: The UF-5000 fully automated flow cytometer based on renowned fluorescence flow cytometry (FFC), represents the latest in urinalysis technology (Photo courtesy of Sysmex Corporation).
Image: The UF-5000 fully automated flow cytometer based on renowned fluorescence flow cytometry (FFC), represents the latest in urinalysis technology (Photo courtesy of Sysmex Corporation).
Urinalysis is a convenient and non‐invasive screening tool for use in both an outpatient and inpatient setting. Automated flow cytometry‐based urine analyzer is increasingly being used to identify and enumerate cells and particles in urine specimens. It measures electrical conductivity which could be transformed to osmolality.

The osmolality of urine, which indicates the quantity of osmotically active particles, can be estimated by the specific gravity (SG). While the SG correlates with urine osmolality, the direct measurement of urine osmolality is more accurate and is considered the gold standard for determining the hydration status of the body and its ability to concentrate urine.

Laboratory Medical Scientists at the Pusan National University Yangsan Hospital (Yangsan, South Korea) collected 270 random urine samples, also known as spot samples, for analysis that included osmolality testing from May 2018 to July 2018. The precision of urine osmolality measurement by the UF‐5000 (Sysmex Corporation, Kobe, Japan) was evaluated for 20 days and four times a day for two concentrations. The linearity and detection capability were evaluated according to the Clinical and Laboratory Standards Institute guidelines. A comparison analysis between the UF‐5000 and the OsmoPro equipment (Advanced Instruments, Norwood, MA, USA) was performed in the laboratory using random urine samples from patients.

The laboratorians reported that the laboratory‐based coefficient variations were less than 5%. Urine osmolality using the UF‐5000 has a verified linear range (R2 = 0.997). Within the comparison analysis, the mean difference was not large (−7.72%), but each differences were largely dispersed with 95% limits of agreement (LoA) from −70.5 to 55.06%, and the mean absolute difference −28.3 mOsm/kg with 95% LoA from −295.13 to 238.45 mOsm/kg. Cohen's kappa value was 0.54. The mean ± SD osmolality measured by the OsmoPro and UF5000 was 450.33 ± 227.51 mOsm/kg and 421.99 ± 221.53 mOsm/kg, respectively.

The authors concluded that the conductivity‐based measurement of osmolality has reliable precision and linearity within a specific range that includes the reference range. Considering the good accessibility of routine analyzer, UF‐5000 can be used to determine whether the urine osmolality is within the reference or should be measured by freezing depression method. The study was published on September 24, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Pusan National University Yangsan Hospital
Sysmex Corporation
Advanced Instruments


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more